2Arroyo V, Gines P, Gerbes AL, et al. Deflnition and diagnostic criteria of refractory ascites and hepatorenal syndrorne in cirrhosis[J]. Hepatology, 1996,23:164.
3Decaux G.Difference is solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985[].Journal of Laboratory and Clinical Medicine.2001
4Gadano A,Moreau R,Pessione F,et al.Aquaretic effects of niravoline, a kappa-opioid agonist, in patients with cirrhosis[].Journal of Hepatology.2000
5Gines P,Jimenez W.Aquaretic agent: a new potential treatment of dilutional hyponatremia in cirrhosis[].Journal of Hepatology.1996
6Gines P,Jimenez W.Aquaretic agents: a new potential treatment of dilutional hyponatremia in cirrhosis[].Journal of Hepatology.1996
7Bosch-Marce M,Jimenez W,Angeli P,et al.Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention[].Gastroenterology.1995
8Bosch-Marce M,Poo JL,Jimenez W,et al.Comparison of two aquaretic drugs (niravoline and OPC-31260) in cirrhotic rats with ascites and water retention[].Journal of Pharmacology and Experimental Therapeutics.1999
9Borroni G,Maggi A,Sangiovanni A,et al.Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients[].Digestive and Liver Disease.2000
10Serradeil-Le-Gal C.Nonpeptide antagonists for vasopressin receptors.Pharmacology of SR 121463A, a new potent and highly selective V2 receptor antagonist[].Advances in Experimental Medicine and Biology.1998
5Kamath PS,Wiesner RH,Malinehoc M,et al.A model to predict Survival in patients with end-stage liver disease[J].Hepatology, 2001,33 (2) : 464-470.
6Angeli P,Wong F,Watson H,et al. Hyponatremia in cirrhosis: Results of a patient population survey[J]. Hepatology,2006,44 (6):1535-1542.
7Londono MC,Cordenas A ,Guevara M,et al. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation [J].Gut,2007,56 (9) : 1283-1290.
8Cole L, Bellomo R, Davenport P,et al. Cytokine removal during continuous renal replacement therapy: an ex-vivo comparison of convection and diffusion[J].Int J Artif Organs,2004, 27(5): 388-397.
9Ogawa R, Kishikawa T, Kudo J.Efective continuous hemofihration and plasma exchange for the treatment of subacute type fulminant hepatic failure[J].Fukucka Igaku Zasshi, 2002,83(8): 338-342.
